Back to Agenda
SESSION 3: THE PIP OPINION
Session Chair(s)
Mette Due Theilade Thomsen, PhD
CEO
PIP Adviser, Denmark
Janina Karres, PhD
Scientific Officer, Paediatric Medicines Office
European Medicines Agency, Netherlands
- Key binding elements
- Best practice for synopsis/outline
Speaker(s)
Key binding elements
Janina Karres, PhD
European Medicines Agency, Netherlands
Scientific Officer, Paediatric Medicines Office
Best practice for synopsis / outline
Mette Due Theilade Thomsen, PhD
PIP Adviser, Denmark
CEO
Have an account?
